[{"data":1,"prerenderedAt":181},["ShallowReactive",2],{"drug-vasopressin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":50,"contraindications":80,"warnings":90,"renal":91,"monitoring":92,"interactions":93,"review":94,"examples":97,"atc":109,"iran":111,"usApproval":127,"links":133,"populations":146},"vasopressin",1,{"fa":7,"en":8},"وازوپرسین","Vasopressin","systemic-hormones",{"fa":11,"en":12},"وازوپرسور (آگونیست V1)","Vasopressor (V1 agonist)",[14],{"name":15,"market":16},"Vasostrict","US",[18,19,7],"vasostrict","pitressin",[21,34,42],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":29,"refs":30},"pre-02","injection","iv","20 units\u002F100 mL premixed (0.2 units\u002FmL)",{"amount":27,"unit":28,"perVolumeMl":5},0.2,"unit",[16],[31],{"source":32,"section":33},"fda-vasostrict","3",{"id":35,"form":23,"route":24,"label":36,"concentration":37,"markets":39,"refs":40},"pre-04","40 units\u002F100 mL premixed (0.4 units\u002FmL)",{"amount":38,"unit":28,"perVolumeMl":5},0.4,[16],[41],{"source":32,"section":33},{"id":43,"form":23,"route":24,"label":44,"concentration":45,"markets":47,"refs":48},"pre-06","60 units\u002F100 mL premixed (0.6 units\u002FmL)",{"amount":46,"unit":28,"perVolumeMl":5},0.6,[16],[49],{"source":32,"section":33},[51,68],{"id":52,"disease":53,"label":54,"population":57,"type":61,"unit":28,"dose":62,"refs":65},"septic","shock",{"fa":55,"en":56},"شوک سپتیک — ۰٫۰۱ تا ۰٫۰۷ واحد\u002Fدقیقه","Septic shock — 0.01–0.07 units\u002Fmin",{"minAge":58},{"value":59,"unit":60},18,"year","infusion",{"perMin":63,"perMinMax":64},0.01,0.07,[66],{"source":32,"section":67},"2.2",{"id":69,"disease":53,"label":70,"population":73,"type":61,"unit":28,"dose":75,"refs":78},"cardiotomy",{"fa":71,"en":72},"شوک پس از جراحی قلب — ۰٫۰۳ تا ۰٫۱ واحد\u002Fدقیقه","Post-cardiotomy shock — 0.03–0.1 units\u002Fmin",{"minAge":74},{"value":59,"unit":60},{"perMin":76,"perMinMax":77},0.03,0.1,[79],{"source":32,"section":67},[81],{"id":82,"severity":83,"text":84,"refs":87},"hyper","block",{"fa":85,"en":86},"حساسیت به وازوپرسین (ویال چنددوزی: یا کلروبوتانول).","Hypersensitivity to vasopressin (multiple-dose vial: or chlorobutanol).",[88],{"source":32,"section":89},"4",[],[],[],[],{"status":95,"reviewer":96,"date":96},"unverified",null,[98,105],{"regimen":52,"formulation":22,"input":99,"expect":102},{"ageYears":100,"weightKg":101},60,70,{"perMin":63,"mlPerHour":103,"upperPerMin":64,"upperMlPerHour":104},3,21,{"regimen":69,"formulation":35,"input":106,"expect":107},{"ageYears":100,"weightKg":101},{"perMin":76,"mlPerHour":108},4.5,[110],"H01BA01",{"status":112,"forms":113,"refs":122},"registered",[114,118],{"code":115,"en":116,"fa":117},"01277","VASOPRESSIN 20PRESSOR U\u002FML AMP","آمپول واسوپرسسین ۲۰ پرسسور واحد \u002F میلی‌لیتر",{"code":119,"en":120,"fa":121},"18427","VASOPRESSIN 40PRESSOR U\u002F2ML AMP","آمپول واسوپرسسین ۴۰ پرسسور واحد \u002F ۲ میلی‌لیتر",[123],{"source":124,"section":125,"url":126},"darooyab-generic","G-2727\u002FVasopressin","https:\u002F\u002Fwww.darooyab.ir\u002FG-2727\u002FVasopressin",{"kind":128,"refs":129,"id":132},"NDA",[130],{"source":32,"section":131},"SPL approval \u002F marketing category","NDA204485",[134,137,141,144],{"kind":135,"url":136,"label":132},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=204485",{"kind":138,"url":139,"label":140},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=b1147beb-743e-4c62-8927-91192447f8b8","FDA Vasostrict",{"kind":142,"url":143,"label":110},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=H01BA01",{"kind":145,"url":126,"label":8},"darooyab",{"pregnancy":147,"lactation":156,"pediatric":164,"geriatric":173},{"level":148,"text":149,"quote":152,"refs":153},"caution",{"fa":150,"en":151},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no available data on Vasostrict ® use in pregnant women to inform a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.",[154],{"source":32,"section":155},"8.1",{"level":148,"text":157,"quote":160,"refs":161},{"fa":158,"en":159},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","There are no data on the presence of vasopressin injection in either human or animal milk, the effects on the breastfed infant, or the effects on milk production.",[162],{"source":32,"section":163},"8.2",{"level":165,"text":166,"quote":169,"refs":170},"not-established",{"fa":167,"en":168},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness of Vasostrict ® in pediatric patients with vasodilatory shock have not been established.",[171],{"source":32,"section":172},"8.4",{"level":148,"text":174,"quote":177,"refs":178},{"fa":175,"en":176},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy [see Warnings and Precautions (5) , Adverse Reactions (6) , and …",[179],{"source":32,"section":180},"8.5",1792115199089]